|
Exchange Received Time  25/09/2018 16:21:16 Exchange Disseminated Time 25/09/2018 16:21:23 Time Taken 00:00:07 | GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/09/2018 ,inter alia, to consider and approve We hereby inform you that, pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015 as amended, a meeting of the Board of Directors of Glenmark Pharmaceuticals Limited ('Company') will be held on September 28, 2018, to consider opportunistic tenders or buybacks of any part of its Singapore listed foreign currency convertible bonds, being, its U.S.$200 million 2 per cent resettable onward starting equity linked securities due June 28, 2022 issued in 2016 ('FCC Bonds') and / or, its U.S.$200 million 4.5% senior notes due 2021 issued in 2016 ('FCY Bonds'), based on market opportunities and conditions from time to time and to delegate powers to operations committee. The Operations Committee, based on market opportunities and conditions, will hold meetings during the next one month to consider and approve the terms and conditions of any tenders or buybacks. |
|
|